EUVIMEDEUVIMED entdecken
Crossref

SIRT1 agonist SRT1720 alleviates cerebral ischemia-reperfusion injury by inhibiting lactate-mediated SOD2 Lactylation and suppressing NCOA4-mediated ferritinophagy-ferroptosis

Xue Qi, Wenqin Song, Yanan Li, Wei Wang, Lan Zhao, Jing Li, Mopu Li, Kefan Wu, Bo Zhao, Wenwei Gao

Cellular Signalling · 2026

DOI: 10.1016/j.cellsig.2026.112396 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cellular Signalling, 2026. Verfasst von Xue Qi und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology, Renmin Hospital of Wuhan University, Wuhan, China. Hauptthemen laut MEDLINE: Superoxide Dismutase, Reperfusion Injury, Sirtuin 1, Heterocyclic Compounds, 4 or More Rings. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 55 Literaturangaben. Gefördert von: Fundamental Research Funds for the Central Universities, Natural Science Foundation of Hubei Province, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cerebral ischemia-reperfusion injury (CIRI) represents a critical pathological process underlying stroke-induced neuronal loss and long-term neurological deficits, characterized by profound oxidative stress and dysregulated iron homeostasis. Although metabolic disturbances such as lactate accumulation are hallmarks of ischemic brain injury, their effects on protein post-translational modifications, particularly lysine lactylation, remain largely unexplored. In this study, male C57BL/6 J mice were subjected to transient middle cerebral artery occlusion (tMCAO) to induce focal CIRI, and microglial cells were exposed to oxygen-glucose deprivation/reoxygenation (OGD/R) in vitro. We found that superoxide dismutase 2 (SOD2) lactylation at lysine 114 (SOD2-K114la) was significantly increased in ischemic brain tissues and OGD/R-treated microglia, accompanied by reduced enzymatic activity. Exogenous lactate treatment elevated SOD2-K114la levels both in vitro and in vivo. Mechanistically, enhanced SOD2 lactylation aggravated oxidative stress and cell injury by activating the NCOA4-mediated ferritinophagy pathway, promoting iron accumulation, lipid peroxidation, and ferroptosis. Importantly, treatment with the SIRT1 agonist SRT1720 effectively inhibited SOD2 lactylation, restored its antioxidant activity, suppressed ferritinophagy and ferroptosis, and attenuated microglial injury. These findings identify the SOD2-K114la/NCOA4 axis as a critical mediator of CIRI progression and suggest that SIRT1 activation may represent a potential therapeutic strategy for mitigating lactylation-dependent ischemic injury.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Superoxide DismutaseReperfusion InjurySirtuin 1Heterocyclic Compounds, 4 or More RingsFerroptosisNuclear Receptor CoactivatorsBrain IschemiaLactic AcidAnimalsMaleMiceMice, Inbred C57BLSuperoxide Dismutase 2MicrogliaOxidative StressAutophagy

Stichwörter der Autor:innen

Cerebral ischemia-reperfusion injuryFerritinophagy-ferroptosisNCOA4SOD2 lactylationSRT1720

Substanzen

Superoxide DismutaseSirtuin 1Heterocyclic Compounds, 4 or More RingsSRT1720Superoxide Dismutase 2Nuclear Receptor CoactivatorsSirt1 protein, mouseLactic Acid

Autor:innen und Institutionen

  • Department of Anesthesiology, Renmin Hospital of Wuhan University, Wuhan, China.
  • Department of Critical Care Medicine, Renmin Hospital of Wuhan University, Wuhan, China.
  • Department of Anesthesiology, Renmin Hospital of Wuhan University, Wuhan, China. Electronic address: zb14526@163.com.
  • Department of Critical Care Medicine, Renmin Hospital of Wuhan University, Wuhan, China. Electronic address: gaowenwei@whu.edu.cn.

Förderung

  • Fundamental Research Funds for the Central Universities
  • Natural Science Foundation of Hubei Province
  • National Natural Science Foundation of China

Zitieren

APA

Qi, X., Song, W., Li, Y., Wang, W., Zhao, L., Li, J., Li, M., Wu, K., Zhao, B., & Gao, W. (2026). SIRT1 agonist SRT1720 alleviates cerebral ischemia-reperfusion injury by inhibiting lactate-mediated SOD2 Lactylation and suppressing NCOA4-mediated ferritinophagy-ferroptosis. Cellular Signalling. https://doi.org/10.1016/j.cellsig.2026.112396

Vancouver

Qi X, Song W, Li Y, Wang W, Zhao L, Li J, et al. SIRT1 agonist SRT1720 alleviates cerebral ischemia-reperfusion injury by inhibiting lactate-mediated SOD2 Lactylation and suppressing NCOA4-mediated ferritinophagy-ferroptosis. Cellular Signalling. 2026. doi:10.1016/j.cellsig.2026.112396

BibTeX
@article{Qi2026,
  author = {Qi, Xue and Song, Wenqin and Li, Yanan and Wang, Wei and Zhao, Lan and Li, Jing and Li, Mopu and Wu, Kefan and Zhao, Bo and Gao, Wenwei},
  title = {SIRT1 agonist SRT1720 alleviates cerebral ischemia-reperfusion injury by inhibiting lactate-mediated SOD2 Lactylation and suppressing NCOA4-mediated ferritinophagy-ferroptosis},
  journal = {Cellular Signalling},
  year = {2026},
  doi = {10.1016/j.cellsig.2026.112396}
}
Kostenlos starten →